ARCHIVES

Letters to the Editor: Burzynski: Reviewers Sought To Discredit Antineoplaston Therapy

This article is from The Cancer Letter archive.

Vol. 24 No. 41 | October 30, 1998

Download PDF Visit The Full Archive

Related Articles

NIH wins A-76 competition for extramural support services.

September 26, 2003

NCI-Approved Clinical Trials

May 26, 2006

MGI Pharma’s Irofulven In Phase III Trial Vs. 5-FU For Advanced Pancreatic Cancer.

March 2, 2001

Group Chairmen Reject DCT’s Agenda For Clinical Trials Review, demand Right To Select Speakers

June 30, 1978

NCI, NIH Hoping 12 Percent Budget Cut Will Not Be Applied To Them

October 2, 1981

OAM Advisor’s Faxes Promote Alternatives, Cassileth Writes To NIH

September 3, 1993